Expired
Lead Plaintiff Deadline
May 13, 2022
Choose your preferred way to stay informed of new case launches and settlement deadlines
(i) the Company's lead investigational product candidate, vadadustat, was not as safe in treating non-dialysis dependent chronic kidney disease patients with anemia as defendants had represented; (ii) as a result, defendants overstated the clinical prospects of a Phase 3 clinical program for vadadustat; (iii) accordingly, defendants also overstated vadadustat’s overall commercial and regulatory prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
In order to be eligible to join the AKBA class action lawsuit, you must have incurred a loss on shares of Akebia purchased during the class period listed above.
If you suffered a loss in Akebia during the relevant time frame or pursuant to the relevant offering(s), you have until May 13, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
TOP
